Cogent Biosciences

Develops precision therapies for patients with genetically defined diseases, including cancers and rare diseases

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-13

About Cogent Biosciences

Cogent Biosciences is a biotechnology company developing small-molecule precision therapies for genetically driven diseases. Its research focuses on diseases linked to genetic mutations and aims to address underlying causes of illness.

The company works on discovery, clinical development and commercialization of therapies for patients with unmet medical needs. Its pipeline includes bezuclastinib, which is being developed for systemic mastocytosis and gastrointestinal stromal tumors.

Cogent has offices in Waltham, Massachusetts, and Boulder, Colorado, where it has a discovery organization. It describes itself as a late-stage clinical development company and has open roles across research, clinical development, medical affairs, operations and commercial functions.

Product: Small-molecule precision therapies in development for genetically defined diseases.

Jobs at Cogent Biosciences

No open positions listed right now.

More biotech & pharma companies

  • Cognitive Research Corporation

    Contract research organization running Phase I-III central nervous system clinical trials for pharma and biotech sponsors
    United StatesBiotech & pharma
    New on Evolc
  • Corcept Therapeutics

    Develops cortisol-modulating medicines for patients with serious diseases
    United StatesBiotech & pharma2 open jobs
  • Countable Labs

    Single-molecule PCR instruments, assays and testing services for genomics and life-science researchers
    Palo Alto, United StatesBiotech & pharma1 open job
    Remote-friendly
  • Cresilon

    Develops plant-based hemostatic gels for emergency medicine and veterinary care
    United StatesBiotech & pharma
    New on Evolc
  • CSBio

    Automated peptide synthesizers for labs, pilot plants and GMP manufacturers, from benchtop to 1000 L scale
    Mountain View, United StatesBiotech & pharma
    New on Evolc
  • Definium Therapeutics

    Develops psychedelic-derived medicines for people with psychiatric and neurodevelopmental disorders
    United StatesBiotech & pharma
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Tag ManagerMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content management

  • ElementorHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

Privacy & consent

  • CookieYesHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Recruiting

  • GreenhouseHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.